Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
[4] [5] The three primary subcutaneous injection sites used for comparable licensed therapies (such as semaglutide and tirzepatide, as described in their UK Summary of Product Characteristics) are: Abdomen the area around the stomach, avoiding the area immediately around the navel Front (anterolateral) thigh the outer-front portion of the upper thigh Upper arms the outer area of the upper arm, typically requiring assistance from another person for self-administration The abdomen is generally considered the most accessible and commonly used site, as it offers a relatively large surface area of subcutaneous fat and is straightforward to self-administer
F 2 -isoprostanes and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders
Dose AI's shot logging feature includes automatic reminders so you never miss a dose
Always consult a qualified healthcare provider before starting any treatment.
